Expression and potential role of CCL4 in CD8+T cells in NSCLC

Ran Chen1, Li Ma1, Chang Jiang1

  • 1Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.

Abstract

Insights

Chemokine ligand 4 (CCL4) is highly expressed in non-small cell lung cancer (NSCLC) and impacts CD8+T cell survival, suggesting CCL4 as a potential immunotherapy target for lung cancer.

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Tumor microenvironment challenges CD8+T cell function in lung cancer.
  • Identifying novel immunotherapy targets is crucial for effective lung cancer treatment.

Purpose of the Study:

  • To identify potential therapeutic targets for lung cancer immunotherapy.
  • To investigate the role of immune infiltration-related genes in non-small cell lung cancer (NSCLC).

Main Methods:

  • Analyzed multiple lung cancer datasets (GSE116959, GSE139032, GSE111894) to identify immune infiltration genes.
  • Evaluated candidate genes using transcriptome, methylation, and single-cell sequencing data.
  • Correlated candidate genes with immunotherapy markers and lung cancer mutations, validating expression via an immunohistochemistry database.

Main Results:

  • Chemokine (C-C motif) ligand 4 (CCL4) showed abnormal overexpression and specific methylation patterns in NSCLC samples.
  • CCL4 expression correlated with immune cell infiltration (B cells, CD8+T cells) and affected CD8+T cell survival.
  • CCL4 was highly expressed in CD8+T cells, linked to cell cycle functions, and positively associated with PD-1, PD-L1, and driver mutations (EGFR, ALK, ROS1).

Conclusions:

  • CCL4 represents a potential therapeutic target for enhancing immunotherapy in NSCLC patients.
  • Targeting CCL4 may restore CD8+T cell function in the lung cancer tumor microenvironment.

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
3.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.2K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K